Fox Jonathan C 4
4 · Eidos Therapeutics, Inc. · Filed Sep 16, 2020
Insider Transaction Report
Form 4
Fox Jonathan C
See Remarks
Transactions
- Sale
Common Stock
2020-09-16$50.16/sh−3,122$156,610→ 383,440 total(indirect: See footnote) - Sale
Common Stock
2020-09-15$50.06/sh−1,000$50,064→ 386,562 total(indirect: See footnote) - Sale
Common Stock
2020-09-14$50.00/sh−111$5,550→ 387,562 total(indirect: See footnote)
Holdings
- 3,294
Common Stock
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2020.
- [F2]The shares are held by Jonathan C. Fox and Suzanne Markel-Fox, Co-Trustees of the Fox Family Trust Dated 17 Dec 2014.
- [F3]Represents the weighted average sale price of the shares sold ranging from $50.00 to $50.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4.
- [F4]Represents the weighted average sale price of the shares sold ranging from $50.015 to $50.36 per share.